Señales en vivo de ARQT | Maximiza tus Ganancias con Getagraph.com

COMPRAR 32024 min ago

@ $12.30

Emitido: 11 abr 2024 @ 12:30

Retorno: -34.96%

Señal anterior: abr 11 - 10:25

Señal anterior: Vender

Retorno: -0.89 %

Live Chart Being Loaded With Signals

Commentary (3 may 2024 @ 16:00):

Stats
Volumen de hoy	2.57M
Volumen promedio	3.87M
Capitalización de mercado	919.77M
EPS	$0 ( 2024-02-27 )
Próxima fecha de ganancias	( $-0.600 ) 2024-05-14
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-2.12
ATR14	$0.0200 (0.25%)

Insider Trading

Date	Person	Action	Amount	type
2024-05-01	Moore Matthew Richard	Buy	4 166	Common Stock
2024-05-02	Moore Matthew Richard	Sell	4 681	Common Stock
2024-05-02	Watanabe Todd Franklin	Sell	13 783	Common Stock
2024-05-02	Matsuda Masaru	Sell	5 016	Common Stock
2024-05-02	Burnett Patrick	Sell	9 555	Common Stock

INSIDER POWER
30.23
Last 98 transactions
Buy: 3 263 487 \| Sell: 1 661 615

Volumen Correlación

Largo: -0.34 (neutral)

Corto: -0.42 (neutral)

Signal:(31.627) Neutral

Arcutis Biotherapeutics Correlación

10 Correlaciones Más Positivas
UCTT	0.963
MRUS	0.96
LRCX	0.958
DEMZ	0.954
SAIA	0.954
LCUT	0.953
LRGE	0.952
KRTX	0.952
META	0.951
FTC	0.95

10 Correlaciones Más Negativas
BIOL	-0.959
WISA	-0.948
RMRM	-0.948
DSWL	-0.947
CYXT	-0.946
SGLB	-0.945
KRKR	-0.942
LSAQ	-0.937
CRCT	-0.935
SRNGW	-0.931

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Arcutis Biotherapeutics Correlación - Moneda/Commodity

0.40
( neutral )

0.47
( neutral )

0.00
( neutral )

0.33
( neutral )

-0.45
( neutral )

-0.07
( neutral )

Arcutis Biotherapeutics Finanzas

Annual	2023
Ingresos:	$59.61M
Beneficio Bruto:	$53.49M (89.74 %)
EPS:	$-3.78

FY	2023
Ingresos:	$59.61M
Beneficio Bruto:	$53.49M (89.74 %)
EPS:	$-3.78

FY	2022
Ingresos:	$3.69M
Beneficio Bruto:	$2.93M (79.54 %)
EPS:	$-5.84

FY	2021
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-5.79

Financial Reports:

No articles found.

Arcutis Biotherapeutics

Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing ARQ-154, a topical foam formulation of roflumilast for the treatment of seborrheic dermatitis and scalp psoriasis; ARQ-252, a selective topical janus kinase type 1 inhibitor for hand eczema and vitiligo; and ARQ-255, a topical formulation of ARQ-252 designed to reach deeper into the skin in order to treat alopecia areata. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California.